Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers (TMB-108)

This study has been completed.
Sponsor:
Collaborators:
Aaron Diamond AIDS Research Center
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
TaiMed Biologics Inc.
ClinicalTrials.gov Identifier:
NCT01292174
First received: February 7, 2011
Last updated: December 17, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)